(Q42288897)

19 October 2017

The protective effect of inhaled leukotriene D4 receptor antagonist ICI 204,219 against exercise-induced asthma (English)

1 reference

19 October 2017

0 references

5

S T Holgate

1 reference

19 October 2017

H K Makker

1

1 reference

19 October 2017

L C Lau

series ordinal

2

1 reference

19 October 2017

H W Thomson

series ordinal

3

1 reference

19 October 2017

S M Binks

series ordinal

4

1 reference

19 October 2017

1 June 1993

1 reference

The American Review of Respiratory Disease

19 October 2017

1 reference

19 October 2017

147

1 reference

19 October 2017

6 Pt 1

1 reference

19 October 2017

1413-1418

1 reference

Leukotrienes and airway responses.

19 October 2017

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_1.1413

Elevated levels of leukotriene C4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_1.1413

Airway Levels of Mast Cell—derived Mediators in Exercise-induced Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_1.1413

Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_1.1413

Prevention of exercise-induced bronchoconstriction by a new leukotriene antagonist (SK&F 104353). A double-blind study versus disodium cromoglycate and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_1.1413

Postexertional airway rewarming and thermally induced asthma. New insights into pathophysiology and possible pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_1.1413

Arterial plasma histamine levels at rest, and during and after exercise in patients with asthma: effects of terbutaline aerosol

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_1.1413

Assessment of bronchoalveolar cell and mediator response to isocapnic hyperpnea in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_1.1413

The preclinical pharmacology of ICI 204,219. A peptide leukotriene antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_1.1413

Effect of a leukotriene antagonist, LY171883, on cold air-induced bronchoconstriction in asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_1.1413

The immunobiology of eosinophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F147.6_PT_1.1413

10.1164/AJRCCM/147.6_PT_1.1413

21 January 2018

Identifiers

DOI

0 references

1 reference